3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in...

European Journal of Cancer 2015 / 09 Vol. 51

3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial

Gulley, J.L., Rajan, A., Spigel, D.R., Iannotti, N., Chandler, J., Wong, D.J.L., Leach, J.L., Edenfield, W.J., Wang, D., Bajars, M., Von Heydebreck, A., Kelly, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31731-2
Date:
September, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed